L6, Infectious Agents and Cancer Flashcards
What percentage of cancers are reportedly attributed to infectious diseases? Which are the two most prevalent?
- Around 15% of cancers
- H.pylori and HPV
List 6 cancers with strong infectious drivers:
- Cervical cancer (HPV)
- Liver cancer (Hep. B and C)
- Lymphomas (viruses)
- Stomach cancer (H.pylori)
- Rarer cancers cause by parasitic infections
- HIV enables several cancers including Karposi’s sarcoma
Early discoveries in tumour virology (1910-1981)
- Rous: transmission experiments for avian sarcomas, discovered RSV
- Identification of papillomavirus in rabbit
- Discovery of murine leukaemia retrovirus
- Adenovirus and SV40 induce tumours in rodents
- First human tumour virus (EBV -> Burkitt’s lymphoma)
- Origin of Src oncogene
- AIDS-related cancers -> KS and non-Hodgkin’s lymphoma
Rous sarcoma experiment
- Removed sarcoma from breast muscle of affected chickens
- Broke down and ground the tissue with sand
- Collected filtrate from fine-pore filter (retaining only small viral particles and removing cell matter)
- Injected filtrate into young chickens who eventually developed sarcomas
How can viruses directly drive carcinogenesis? (x3)
- DNA damage response and subsequent mutation due to integration of viral DNA into cellular DNA (retroviruses; HPV, EBV etc)
- Modified viral oncogenes after integration into host cell DNA
- Modified host genes integrated into viral genome act as oncogenes
How can viruses indirectly drive carcinogenesis? (x5)
- Detection of virus by PAMPs/DAMPs can induce chronic inflammation
- Oxidative stress (ROS/RNS, mitochondrial stress, ER stress pathway)
- Immunosupression by virus (HIV-1/2)
- Prevention of apoptosis
- Induction of chromosomal instability and translocations
Structure of RSV:
- env: surface glycoprotein (facilitating uptake through interacting with host)
- gag: protein coat
- pol: reverse transcriptase
- lipid bilayer acquired from infected cell
Retrovirus lifecycle:
- Entry into cell and shedding viral envelope
- Reverse transcriptase makes DNA/RNA and then DNA/DNA double helix
- Integration of host DNA copy into host chromosome
- Assembly of many new virus particles, each containing reverse transcriptase, into protein coats
RSV monolayer experiment:
Studying how virus conveys cancer
- Cell monolayer infected with RSV particle
- Changed behaviour of cell; foci lose contact-contact inhibition so are no longer being signalled to cease growing once monolayer complete
Temperature mutant RSV experiments:
- Normal morphology cells infected with ts RSV mutant at 37 degrees -> produced transformed morphology
- At increased temperature (41 degrees), transformed morphology was lost -> normal morphology
- Shifting temperature back down restored cancerous phenotype
- As such, the cancerous phenotype requires presence of active viral proteins
Proposed model for source of v-src:
- RSV has extra gene, src in genome compared to ALV
- Host cell chromosomal DNA contains c-src which integrates with dsDNA provirus (from ALV virion), once transcribed as v-src is packaged into capsid as RSV
Give the role of the Src oncogene: Mechanism of activation?
Src produced a protein kinase which signals for proliferation
- In inactive form, C-terminal tail is phosphorylated
- C terminal tail dephosphorylation activates activation loop, triggering autophosphorylation of src-activator
- Activation loop phosphorylated and catalytic cleft thus exposed -> ACTIVE -> signals proliferation
- In normal cells this is initiated in certain conditions whereas in v-src oncogenes it is constitutively activated
What makes v-Src oncogenic compared to the gene in a healthy cell?
- Lacks Tyrosine-527 on c-terminal tail; not inactivated by phosphorylation
- Constitutively active
How does ALV induce cancer?
- Insertional mutagenesis
- ALV: Slowly transforming retrovirus
- Provirus inserts randomly into host genome
- Very occasionally, inserts upstream of c-myc (1 in 10 million)
- Induction of cancer is a rare event
HPV and cervical cancer: Statistics
- 4th most common cancer in women worldwide
- 86% of cases in the developing world
- Issue of transmission; compared ot breast cancer, much higher prevalence in 18-44